These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36581723)

  • 1. Age-Dependent Clinicopathological Characteristics of Patients with T1b Papillary Thyroid Carcinoma: Implications for the Possibility of Active Surveillance.
    Won HR; Jeon E; Heo DB; Chang JW; Shong M; Kim JR; Ko H; Kang YE; Yi HS; Lee JH; Joung KH; Kim JM; Lee Y; Kim SW; Jeong YJ; Ji YB; Tae K; Koo BS;
    Ann Surg Oncol; 2023 Apr; 30(4):2246-2253. PubMed ID: 36581723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid Lobectomy for T1 Papillary Thyroid Carcinoma in Pediatric Patients.
    Sudoko CK; Jenks CM; Bauer AJ; Isaza A; Mostoufi-Moab S; Surrey LF; Bhatti TR; Franco A; Adzick NS; Kazahaya K
    JAMA Otolaryngol Head Neck Surg; 2021 Nov; 147(11):943-950. PubMed ID: 34554217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the T1 subdivision correlate with the risk of recurrence of papillary thyroid cancer?
    Chereau N; Trésallet C; Noullet S; Godiris-Petit G; Tissier F; Leenhardt L; Menegaux F
    Langenbecks Arch Surg; 2016 Mar; 401(2):223-30. PubMed ID: 26957089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SHOULD MULTIFOCAL PAPILLARY THYROID CARCINOMAS CLASSIFIED AS T1A WITH A TUMOR DIAMETER SUM OF 1 TO 2 CENTIMETERS BE RECLASSIFIED AS T1B?
    Tam AA; Ozdemir D; Ogmen BE; Fakı S; Dumlu EG; Yazgan AK; Ersoy R; Cakır B
    Endocr Pract; 2017 May; 23(5):526-535. PubMed ID: 28156153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of active surveillance in patients with clinically T1b papillary thyroid carcinoma ≤1.5 cm in preoperative ultrasonography: MASTER study.
    Ju SH; Ji YB; Song M; Lim JY; Heo DB; Kim MG; Chang JW; Won HR; Kang YE; Ku EJ; Kim M; Lee EK; Choi JY; Yu HW; Park YJ; Choe JH; Koo BS
    Eur Thyroid J; 2024 Apr; 13(2):. PubMed ID: 38484463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid Lobectomy for T1b-T2 Papillary Thyroid Cancer with High-Risk Features.
    Suman P; Razdan SN; Wang CE; Tulchinsky M; Ahmed L; Prinz RA; Winchester DJ
    J Am Coll Surg; 2020 Jan; 230(1):136-144. PubMed ID: 31672668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with Oncocytic Variant Papillary Thyroid Carcinoma Have a Similar Prognosis to Matched Classical Papillary Thyroid Carcinoma Controls.
    Carr AA; Yen TWF; Ortiz DI; Hunt BC; Fareau G; Massey BL; Campbell BH; Doffek KL; Evans DB; Wang TS
    Thyroid; 2018 Nov; 28(11):1462-1467. PubMed ID: 30215297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lateral Lymph Node Metastases in T1a Papillary Thyroid Carcinoma: Stratification by Tumor Location and Size.
    Zhang X; Chen W; Fang Q; Fan J; Feng L; Guo L; Liu S; Ge H; Du W
    Front Endocrinol (Lausanne); 2021; 12():716082. PubMed ID: 34335480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T1a Versus T1b Differentiated Thyroid Cancers: Do We Need to Make the Distinction?
    Anderson KL; Youngwirth LM; Scheri RP; Stang MT; Roman SA; Sosa JA
    Thyroid; 2016 Aug; 26(8):1046-52. PubMed ID: 27266722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of multifocality in papillary thyroid carcinoma.
    Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the role of prophylactic bilateral central neck lymph node dissection in patients with papillary thyroid carcinoma: a case controlled study.
    Shahriarirad R; Meshkati Yazd SM; Zahedi R; Mokhtari Ardekani A; Rekabi MM; Nasiri S
    Updates Surg; 2023 Apr; 75(3):679-689. PubMed ID: 36527603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Clinically Solitary Papillary Thyroid Carcinoma Patients According to Risk-Scoring Model for Contralateral Occult Carcinoma.
    Feng JW; Ye J; Wu WX; Pan H; Qin AC; Jiang Y; Wu BQ
    Front Endocrinol (Lausanne); 2020; 11():553577. PubMed ID: 33133013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Risk Factors Associated With Central Lymph Node Metastasis in Papillary Thyroid Carcinoma With cT1N0 Stage.
    Zhao YZ; He NA; Ye XJ; Jin F; Li MX; Jiang X
    Front Endocrinol (Lausanne); 2022; 13():880911. PubMed ID: 35733781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Completion thyroidectomy may not be required for papillary thyroid carcinoma with multifocality, lymphovascular invasion, extrathyroidal extension to the strap muscles, or five or more central lymph node micrometastasis.
    Beom Heo D; Piao Y; Hee Lee J; Ju SH; Yi HS; Su Kim M; Won HR; Won Chang J; Seok Koo B; Eun Kang Y
    Oral Oncol; 2022 Nov; 134():106115. PubMed ID: 36108524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total tumor diameter: the neglected value in papillary thyroid microcarcinoma.
    Feng JW; Pan H; Wang L; Ye J; Jiang Y; Qu Z
    J Endocrinol Invest; 2020 May; 43(5):601-613. PubMed ID: 31749082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Evaluation of Clinicopathological Factors Effective in the Development of Central and Lateral Lymph Node Metastasis in Papillary Thyroid Cancer.
    Aydin Buyruk B; Kebapci N; Yorulmaz G; Buyruk A; Kebapci M
    J Natl Med Assoc; 2018 Aug; 110(4):384-390. PubMed ID: 30126565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases.
    Matsuzu K; Sugino K; Masudo K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Uruno T; Suzuki A; Magoshi S; Akaishi J; Masaki C; Kawano M; Suganuma N; Rino Y; Masuda M; Kameyama K; Takami H; Ito K
    World J Surg; 2014 Jan; 38(1):68-79. PubMed ID: 24081532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lateral neck metastases in the ipsilateral and contralateral compartments of papillary thyroid carcinoma located in one lobe.
    Kim SY; Kim SM; Chang H; Kim BW; Lee YS; Chang HS; Park CS
    ANZ J Surg; 2019 Nov; 89(11):E498-E501. PubMed ID: 31566299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active Surveillance for T1bN0M0 Papillary Thyroid Carcinoma.
    Sakai T; Sugitani I; Ebina A; Fukuoka O; Toda K; Mitani H; Yamada K
    Thyroid; 2019 Jan; 29(1):59-63. PubMed ID: 30560718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pattern and Predictive Factors of Metastasis in Lymph Nodes Posterior to the Right Recurrent Laryngeal Nerve in Papillary Thyroid Carcinoma.
    Zhou M; Duan Y; Ye B; Wang Y; Li H; Wu Y; Chen P; Zhu J; Jing C; Wu Y; Wang X
    Front Endocrinol (Lausanne); 2022; 13():914946. PubMed ID: 35923627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.